A vulnerability in an application, API, cloud environment or network could expose sensitive information, interrupt operations or put an important customer contract at risk. Identify exploitable security weaknesses and get clear priorities for resolving them.
Healthcare and pharmaceutical systems change as new applications, integrations, cloud services and user roles are introduced. Penetration testing helps establish whether those changes have created weaknesses that an attacker could exploit.
Not sure what should be included? We can review your requirement and help define the appropriate testing scope before preparing a quotation.
Ultralink provides cyber security penetration testing across the systems healthcare organisations and pharmaceutical companies depend on. Each service is scoped around the authorised environment, relevant attack paths and the reason testing is required.
Assess patient portals, healthcare SaaS platforms, pharmaceutical applications, supplier portals and internal business systems.
Our web application penetration testing examines areas such as authentication, session management, access control, input handling, data exposure and application logic to identify weaknesses that could enable unauthorised activity.
Test APIs connecting applications, cloud platforms, mobile services, internal systems and authorised third parties.
API penetration testing assesses authentication, authorisation, input validation, data exposure and access to restricted functions. Testing can cover different user roles and integration points within the agreed scope.
Identify exploitable weaknesses across servers, network devices, remote-access services, exposed ports and security configurations.
External network penetration testing assesses internet-facing systems, while internal testing examines risks that could be exploited from within an authorised network environment.
Assess authorised cloud-hosted applications, workloads, identities and access controls for weaknesses that could expose information or provide unintended access to resources.
Testing is planned around the cloud platform, provider requirements and approved components.
Assess mobile applications and their supporting APIs for weaknesses involving authentication, communication, data storage, session security and access controls.
Mobile application testing should be included only where confirmed within Ultralink’s available testing capability.
Technical severity alone does not show the complete business risk of a vulnerability.
Within a healthcare environment, a weakness could expose sensitive health information, affect a patient-facing service or provide a route into a connected system. For a pharmaceutical company, it could place research, commercial information, operational applications or supplier relationships at risk.
Our healthcare penetration testing services consider the system's purpose, the information it processes and the potential operational or commercial impact of exploitation.
Testing may involve:
We establish why testing is required, which systems may be involved, the intended outcome and any contractual, customer or assessment deadline.
Targets, user roles, access requirements, exclusions, responsibilities, testing restrictions and rules of engagement are documented before testing begins.
Appropriate automated techniques support coverage and discovery. Manual penetration testing is then used to validate relevant weaknesses, examine attack paths and assess what an attacker could potentially achieve.
Verified findings are documented with supporting evidence, affected components, severity, potential impact and recommended remediation actions.
We explain the findings to relevant stakeholders and answer technical questions. Agreed vulnerabilities can be retested after remediation where this is included in the engagement.
A penetration testing report must help decision-makers understand the exposure while giving technical teams enough evidence to address it.
Depending on the agreed engagement, you will receive:
A concise overview of the most important findings and their potential operational or commercial impact.
Verified vulnerabilities, affected systems, supporting evidence, severity ratings and recommended remediation actions.
Findings organised according to exploitability, exposure and potential impact so your team can address the most significant risks first.
Clear recommendations for your developers, internal IT team or existing technology provider.
A stakeholder review to explain the results and agreed retesting after remediation, where included in the quotation.
Ultralink can separately scope remediation support for eligible application, cloud or infrastructure findings. The findings remain evidence-based whether remediation is completed by Ultralink, your internal team or another provider.
A properly scoped penetration test may provide evidence for NHS supplier assurance, ISO 27001 security activities, relevant PCI DSS requirements, pharmaceutical supplier reviews, procurement processes, customer assessments and cyber-insurance requests.
Where a customer, assessor or tender specifies testing criteria, we review those requirements when defining the scope and reporting format.
Penetration testing can support a wider security or compliance programme. However, a penetration test alone does not make an organisation compliant with the NHS Data Security and Protection Toolkit, ISO 27001, PCI DSS or UK GDPR.
The cost of penetration testing services in the UK depends on the environment and level of testing required. Key pricing factors include:
Your penetration testing quote will define the authorised scope, testing approach, deliverables, assumptions, exclusions and retesting arrangements. You will know what is covered before the engagement begins.
The value of a penetration test depends on the quality of its scope, the relevance of its findings and your team’s ability to resolve the identified risks.
We clearly explain the proposed scope, delivery responsibilities and available evidence before work begins. If specialist delivery support is required, the arrangement and responsibilities will be confirmed transparently.
Tell us which applications, APIs, cloud environments or infrastructure you need assessed, why the test is required and your preferred completion date.
Ultralink will review the requirement and recommend an appropriate scope, testing approach and quotation. Before work begins, you will understand what is included, what evidence you will receive and how retesting will be handled.
Prioritise systems that are internet-facing, process sensitive information, support important operations or have recently changed. These may include web applications, APIs, cloud-hosted systems and internal or external infrastructure. We can help define the appropriate scope before quoting.
Vulnerability scanning uses automated tools to identify potential weaknesses. Penetration testing combines appropriate automated techniques with manual investigation to validate relevant findings, examine attack paths and assess their potential impact.
Testing a live environment may be possible after the risks, permissions and restrictions have been assessed. Depending on the system, controlled testing windows, excluded techniques, additional monitoring or a representative test environment may be recommended.
The timescale depends on the number of systems, application complexity, user roles, access arrangements and required testing depth. The quotation will state the anticipated testing and reporting period.
Yes. The report will document validated findings, affected systems, supporting evidence, severity and recommended remediation. An executive summary and stakeholder review can help non-technical decision-makers understand the priorities.
Retesting arrangements are confirmed in the quotation. Where included, agreed vulnerabilities are assessed again after remediation to determine whether the identified weaknesses have been resolved effectively.
Tell us which applications, APIs, cloud environments or infrastructure you need assessed and we will recommend an appropriate scope and quotation.
